Duquesne Family Office »

Monte Rosa Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.2M 298k 24.20

More positions owned by Duquesne Family Office

Natera (NTRA)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ishares Msci Brazil Etf (EWZ)
Amazon (AMZN)
Stmicroelectronics N V Ny Registry (STM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Cdw (CDW)
Bbb Foods Cl A Com (TBBB)
Alphabet Cap Stk Cl A (GOOGL)
Seagate Technology Hldngs Pl Ord Shs (STX)
Fox Corp Cl A Com (FOXA)
Hldgs (UAL)
Sea Sponsord Ads (SE)

View all positions for Duquesne Family Office

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
T. Rowe Price Associates
TCG Crossover Management
Vestal Point Capital
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Versant Venture Management
Braidwell
Geode Capital Management
American Century Companies
Marshall Wace

View all funds holding Monte Rosa Therapeutics